Development and validation of nomograms for predicting survival in patients with de novo metastatic triple-negative breast cancer

Metastatic triple-negative breast cancer (mTNBC) is a heterogeneous disease with a poor prognosis. Individualized survival prediction tool is useful for this population. We constructed the predicted nomograms for breast cancer-specific survival (BCSS) and overall survival (OS) using the data identif...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mao-Shan, Liu, Peng-Cheng, Yi, Jin-Zhi, Xu, Li, He, Tao, Wu, Hao, Yang, Ji-Qiao, Lv, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424305/
https://www.ncbi.nlm.nih.gov/pubmed/36038627
http://dx.doi.org/10.1038/s41598-022-18727-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424305/
https://www.ncbi.nlm.nih.gov/pubmed/36038627
http://dx.doi.org/10.1038/s41598-022-18727-2

Ejemplares similares